Effects of ulinastatin on inflammatory factors during cardiopulmo nary bypass
LI Tian-cheng
Abstract
LI Tian-cheng
Abstract
Objective To investigate the effects of ulinastatin on tumor necros is factor(TNF-α), endothelin-1(ET-1), throbonxane A 2(TXA 2), maleic dialde hyde (MDA)and superoxide dismutase(SOD) during the operation on heart with cardio pulmonary bypass (CPB).Methods 30 ASA Ⅱ~Ⅲ patients who underwent elective heart surgery w ere divided into two groups randomly,15 patients in ulinastatin group rece ived ulinastatin 20 000 U/kg,15 patients in control group received sam e volume of saline instead of ulinastatin. Arterial blood samples were taken at the beginning of surgery(t 1), 10 min after aortic release(t 2), 10 min(t 3) and 1 h (t 4) after discontinuation of CPB for blood gas analysis, venous blood samp les were taken at the same time for determination of plasma levels of TNF-α, ET-1, TXA 2, MDA and SOD activity.Results There was no significant diff ere nce between two groups in plasma TNF-α, ET-1, TXA 2, MDA level and SOD activit y before CPB in both groups. The plasma level of TNF-α increased at t 2 in both gr oups and was still high at t 4 in control group but not in ulinastatin group. T he plasma level of ET-1 was increased at t 2 and then decreased in both groups. The plasma level of MDA at t 2 and t 3 was higher than that at baseline in both g roup s, and the level of it in ulinastatin group was significantly lower than that in control group, it returned to the baseline at t 4 in ulinastatin group but was s till high in control group. The plasma activity of SOD increased significantly a t t 2 and t 4 in both groups, and the activity in ulinastatin group was higher tha n that in control group(P0.01). The plasma level of TXA 2 in ulin astatin group w as significantly lower than that in control group at t 2 and t 3, and it retur ned to baseline at t 4 in ulinastatin group. Conclusions Ulinastatin c an improve the respiratory function during CPB by inhibiting the production of TNF -α, TXA 2 and enhancing the plasma activity of SOD.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effects of ulinastatin on tumor necros is factor(TNF-α), endothelin-1(ET-1), throbonxane A 2(TXA 2), maleic dialde hyde (MDA)and superoxide dismutase(SOD) during the operation on heart with cardio pulmonary bypass (CPB).Methods 30 ASA Ⅱ~Ⅲ patients who underwent elective heart surgery w ere divided into two groups randomly,15 patients in ulinastatin group rece ived ulinastatin 20 000 U/kg,15 patients in control group received sam e volume of saline instead of ulinastatin. Arterial blood samples were taken at the beginning of surgery(t 1), 10 min after aortic release(t 2), 10 min(t 3) and 1 h (t 4) after discontinuation of CPB for blood gas analysis, venous blood samp les were taken at the same time for determination of plasma levels of TNF-α, ET-1, TXA 2, MDA and SOD activity.Results There was no significant diff ere nce between two groups in plasma TNF-α, ET-1, TXA 2, MDA level and SOD activit y before CPB in both groups. The plasma level of TNF-α increased at t 2 in both gr oups and was still high at t 4 in control group but not in ulinastatin group. T he plasma level of ET-1 was increased at t 2 and then decreased in both groups. The plasma level of MDA at t 2 and t 3 was higher than that at baseline in both g roup s, and the level of it in ulinastatin group was significantly lower than that in control group, it returned to the baseline at t 4 in ulinastatin group but was s till high in control group. The plasma activity of SOD increased significantly a t t 2 and t 4 in both groups, and the activity in ulinastatin group was higher tha n that in control group(P0.01). The plasma level of TXA 2 in ulin astatin group w as significantly lower than that in control group at t 2 and t 3, and it retur ned to baseline at t 4 in ulinastatin group. Conclusions Ulinastatin c an improve the respiratory function during CPB by inhibiting the production of TNF -α, TXA 2 and enhancing the plasma activity of SOD.
Key concepts: Ulinastatin, Medicine, Venous blood, Saline, Anesthesia, Superoxide dismutase, Gastroenterology, Internal medicine